Therapeutic endoscopy and endoscopic ultrasound for gastrointestinal malignancies

Expert Review of Anticancer Therapy

Volumn 5, Issue 4, 2005, Pages 705-718

  Wong, Robert F ^a   Bhutani, Manoop S ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Endoscopic ultrasonography; Gastrointestinal endoscopy; Gastrointestinal neoplasm; Treatments

Indexed keywords

ALCOHOL; AMINOLEVULINIC ACID; ANTIBIOTIC AGENT; FLUOROURACIL; GEMCITABINE; ONYX 015; PORPHYRIN; STEROID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BACTERIAL INFECTION; BARRETT ESOPHAGUS; CANCER PALLIATIVE THERAPY; CANCER STAGING; CELIAC PLEXUS; CLINICAL TRIAL; CYTOTOXICITY; DIGESTIVE SYSTEM CANCER; DRUG TOLERABILITY; DUODENUM PERFORATION; DYSPHAGIA; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FLU LIKE SYNDROME; FLUID RETENTION; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL RADIOGRAPHY; GASTROINTESTINAL SURGERY; GASTROSCOPY; HUMAN; HYPERTHERMIC THERAPY; HYPOTENSION; INJECTION SITE REACTION; LYMPH NODE METASTASIS; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; NEUROLYSIS; NONHUMAN; PANCREAS ADENOCARCINOMA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; RADIOFREQUENCY ABLATION; REVIEW; SIDE EFFECT; STENT; TREATMENT INDICATION;

ENDOSCOPY; ENDOSONOGRAPHY; GASTROINTESTINAL NEOPLASMS; HUMANS;

EID: 24044528145     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.5.4.705     Document Type: Review

References (81)

1. Tamerisa R, Irisawa A, Bhutani MS. Endoscopic ultrasound in the diagnosis, staging, and management of gastrointestinal and adjacent malignancies. Med. Clin. North Am. 89(1), 139-158 (2005).
2. Adachi Y, Shiraishi N, Kitano S. Modern treatment of early gastric cancer: review of the Japanese experience. Dig. Surg. 19(5), 333-339 (2002).
3. Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118(4), 670-677 (2000).
4. Inoue H. Endoscopic mucosal resection for the entire gastrointestinal mucosal lesions. Gastrointest. Endosc. Clin. N. Am. 11(3), 459-478 (2001).
5. May A, Gossner L, Pech O et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur. J. Gastroenterol. Hepatol. 14(10), 1085-1091 (2002).
6. Soetikno RM, Gotoda T, Nakanishi Y, Soehendra N. Endoscopic mucosal resection. Gastrointest. Endosc. 57(4), 567-579 (2003).
7. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123(4), 432-439 (1998).
8. van Sandick JW, van Lanschot JJ, Ten Kate FJ et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 88(11), 2429-2437 (2000).
9. Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann. Surg. 232(6), 733-742 (2000).
10. Ruol A, Merigliano S, Baldan N et al. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis. Esophagus. 10(3), 190-195 (1997).
11. Rice TW, Zuccaro G Jr, Adelstein DJ et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann. Thorac. Surg. 65(3), 787-792 (1998).
12. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett's oesophagus. Br. J. Surg. 84(10), 1470-1473 (1997).
13. Ahmad NA, Kochman ML, Long WB, Furth EE, Ginsberg GG. Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest. Endosc. 55(3), 390-396 (2002).
14. Ishiguro A, Uno Y, Ishiguro Y, Munakata A, Morita T. Correlation of lifting versus non-lifting and microscopic depth of invasion in early colorectal cancer. Gastrointest. Endosc. 50(3), 329-333 (1999).
15. Fujishiro M, Yahagi N, Kashimura K et al. Comparison of various submucosal injection solutions for maintaining mucosal elevation during endoscopic mucosal resection. Endoscopy 36(7), 579-583 (2004).
16. Yamamoto H, Kawata H, Sunada K et al. Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood. Endoscopy 35(8), 690-694 (2003).
17. Yamamoto H, Kawata H, Sunada K et al. Success rate of curative endoscopic mucosal resection with circumferential mucosal incision assisted by submucosal injection of sodium hyaluronate. Gastrointest. Endosc. 56(4), 507-512 (2002).
18. Ono H, Kondo H, Gotoda T et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48(2), 225-229 (2001).
19. Miyamoto S, Muto M, Hamamoto Y et al. A new technique for endoscopic mucosal resection with an insulated-tip electrosurgical knife improves the completeness of resection of intramucosal gastric neoplasms. Gastrointest. Endosc. 55(4), 576-581 (2002).
20. Kondo H, Gotoda T, Ono H et al. Percutaneous traction-assisted EMR by using an insulation-tipped electrosurgical knife for early stage gastric cancer. Gastrointest. Endosc. 59(2), 284-288 (2004).
21. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest. Endosc. 52(3), 328-332 (2000).
22. Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin. Gastroenterol. Hepatol. 1(4), 252-257 (2003).
23. Tanabe S, Koizumi W, Mitomi H et al. Clinical outcome of endoscopic aspiration mucosectomy for early stage gastric cancer. Gastrointest. Endosc. 56(5), 708-713 (2002).
24. Giovannini M, Bories E, Pesenti C et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36(9), 782-787 (2004).
25. Spechler SJ. Clinical practice. Barrett's esophagus. N. Engl J Med. 346(11), 836-842 (2002).
26. Selvasekar CR, Birbeck N, McMillan T, Wainwright M, Walker SJ. Photodynamic therapy and the alimentary tract. Aliment. Pharmacol. Ther. 15(7), 899-915 (2001).
27. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest. Endosc. 58(2), 183-188 (2003).
28. Wolfsen HC, Woodward TA, Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo. Clin. Proc. 77(11), 1176-1181 (2002).
29. Peters FP, Kara MA, Rosmolen WD et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest. Endosc. 61(4), 506-514 (2005).
30. Litle VR, Luketich JD, Christie NA et al. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann. Thorac. Surg. 76(5), 1687-1692; discussion 1692-1683 (2003).
31. Moghissi K, Dixon K, Thorpe JA, Stringer M, Moore PJ. The role of photodynamic therapy (PDT) in inoperable oesophageal cancer. Eur. J. Cardiothorac. Surg. 17(2), 95-100 (2000).
32. Weston AP, Sharma P. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am. J. Gastroenterol. 97(12), 2998-3006 (2002).
33. Morris CD, Byrne JP, Armstrong GR, Attwood SE. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation. Br. J. Surg. 88(10), 1357-1362 (2001).
34. Attwood SE, Lewis CJ, Caplin S, Hemming K, Armstrong G. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin. Gastroenterol. Hepatol. 1(4), 258-263 (2003).
35. Dallal HJ, Smith GD, Grieve DC et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest. Endosc. 54(5), 549-557 (2001).
36. Sihvo EI, Pentikainen T, Luostarinen ME, Ramo OJ, Salo JA. Inoperable adenocarcinoma of the oesophagogastric junction: a comparative clinical study of laser coagulation versus self-expanding metallic stents with special reference to cost analysis. Eur. J. Surg. Oncol. 28(7), 711-715 (2002).
37. Alexander P, Mayoral W, Reilly HF III et al. Endoscopic Nd:YAG laser with aggressive multimodality therapy for locally advanced esophageal cancer. Gastrointest. Endosc. 55(6), 674-679 (2002).
38. Monga SP. Wadleigh R, Sharma A et al. Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer. Am. J. Clin. Oncol. 23(4), 386-392 (2000).
39. Harbord M, Dawes RF, Barr H et al. Palliation of patients with dysphagia due to advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel. Gastrointest. Endosc. 56(5), 644-651 (2002).
40. Baron TH, Harewood GC. Enteral self-expandable stents. Gastrointest. Endosc. 58(3), 421-433 (2003).
41. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N. Engl. J. Med. 344(22), 1681-1687 (2001).
42. Sebastian S, Johnston S, Geoghegan T, Torreggiani W, Buckley M. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am. J. Gastroenterol. 99(10), 2051-2057 (2004).
43. Stelzner M. 2003 SSAT-AGA-ASGE Workshop on 'Palliative Therapy of Rectal Cancer'. Summary statement. J. Gastrointest. Surg. 8(3), 253-258 (2004).
44. Law WL, Choi HK, Chu KW. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br. J. Surg. 90(11), 1429-1433 (2003).
45. Carne PW, Frye JN, Robertson GM, Frizelle FA. Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis. Colon Rectum. 47(9), 1455-1461 (2004).
46. Maetani I, Tada T, Ukita T et al. Self-expandable metallic stent placement as palliative treatment of obstructed colorectal carcinoma. J. Gastroenterol. 39(4), 334-338 (2004).
47. Hunerbein M, Krause M, Moesta KT, Rau B, Schlag PM. Palliation of malignant rectal obstruction with self-expanding metal stents. Surgery 137(1), 42-47 (2005).
48. Spinelli P, Mancini A. Use of self-expanding metal stents for palliation of rectosigmoid cancer. Gastrointest. Endosc. 53(2), 203-206 (2001).
49. Watson AJ, Shanmugam V, Mackay I et al. Outcomes after placement of colorectal stents. Colorectal Dis. 7(1), 70-73 (2005).
50. Meisner S, Hensler M, Knop FK, West F, Wille-Jorgensen P. Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center. Dis. Colon Rectum. 47(4), 444-450 (2004).
51. Camunez F, Echenagusia A, Simo G et al. Malignant colorectal obstruction treated by means of self-expanding metallic stents: effectiveness before surgery and in palliation. Radiology 216(2), 492-497 (2000).
52. Tamim WZ, Ghellai A, Counihan TC et al. Experience with endoluminal colonic wall stents for the management of large bowel obstruction for benign and malignant disease. Arch. Surg. 135(4), 434-438 (2000).
53. Isenberg GA. Catheter-probe-assisted endoluminal US. Gastrointest. Endosc. 60(4), 608-622 (2004).
54. Oto A, Bhutani M. Introduction to diagnostic ultrasonography and endosonography. In: Digital Human Anatomy and Endoscopic Ultrasonography. Bhutani M, Deutsch J (Eds). BC Decker, London, UK, 13-25 (2005).
55. Wiersema MJ, Wiersema LM. Endosonography-guided celiac plexus neurolysis. Gastrointest. Endosc. 44(6), 656-662 (1996).
56. Hoffman BJ. EUS-guided celiac plexus block/neurolysis. Gastrointest. Endosc. 56(Suppl. 4), S26-S28 (2002).
57. Levy MJ, Wiersema MJ. EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest. Endosc. 57(7), 923-930 (2003).
58. Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest. Endosc. 54(3), 316-324 (2001).
59. Wong GY, Schroeder DR, Carns PE et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 291(9), 1092-1099 (2004).
60. Gress F, Schmitt C, Sherman S, Ikenberry S, Lehman G. A prospective randomized comparison of endoscopic ultrasound- and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am. J. Gastroenterol. 94(4), 900-905 (1999).
61. Gress F, Schmitt C, Sherman S et al. Endoscopic ultrasound-guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am. J. Gastroenterol. 96(2), 409-416 (2001).
62. Prat F, Lafon C, De Lima DM et al. Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: results of a pilot study. Gastrointest. Endosc. 56(6), 909-915 (2002).
63. Chan HH, Nishioka NS, Mino M et al. EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointest. Endosc. 59(1), 95-99 (2004).
64. Goldberg SN, Matlery S, Gazelle GS, Brugge WR. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest. Endosc. 50(3), 392-401 (1999).
65. Günter E, Lingenfelser T, Eitelbach F, Müller H, Ell C. EUS-guided ethanol injection for treatment of a GI stromal tumor. Gastrointest. Endosc. 57(1), 113-115 (2003).
66. Barclay RL, Perez-Miranda M, Giovannini M. EUS-guided treatment of a solid hepatic metastasis. Gastrointest. Endosc. 55(2), 266-270 (2002).
67. Gan SI, Thompson CC, Lauwers GY, Bounds BC, Brugge WR. Ethanol lavage of pancreatic cystic lesions: Initial pilot study. Gastrointest. Endosc. 61(6), 746-752 (2005).
68. Chang KJ, Nguyen PT, Thompson JA et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 88(6), 1325-1335 (2000).
69. Hecht JR, Bedford R, Abbruzzese JL et al. A Phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin. Cancer Res. 9(2), 555-561 (2003).
70. Mulvihill S, Warren R, Venook A et al. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a Phase I trial. Gene Ther. 8(4), 308-315 (2001).
71. Chang K, Senzer N, Chung T et al. A novel gene transfer therapy against pancreatic cancer (TNFerade) delivered by endoscopic ultrasound (EUS) and percutaneous guided fine needle injection (FNI). Gastrointest. Endosc. 59(5), AB92 (2004).
72. Lohnert M, Doniec JM, Kovacs G, Schroder J, Dohrmann P. New method of radiotherapy for anal cancer with three-dimensional tumor reconstruction based on endoanal ultrasound and ultrasound-guided afterloading therapy. Dis. Colon Rectum. 41(2), 169-176 (1998).
73. Doniec MJ, Loehnert MS, Kovacs G, Kremer B, Grimm HA. Rectal EUS guided HDR-brachytherapy in patients with anal and perianal malignancies. Gastrointest. Endosc. 51(4), AB106 (2000).
74. Mallery S, Matlock J, Freeman ML. EUS-guided rendezvous drainage of obstructed biliary and pancreatic ducts: report of 6 cases. Gastrointest. Endosc. 59(1), 100-107 (2004).
75. Kahaleh M, Wang P, Shami VM, Tokar J, Yeaton P. EUS-guided transhepatic cholangiography: report of 6 cases. Gastrointest. Endosc. 61(2), 307-313 (2005).
76. Hawes RH. New approaches in interventional EUS. Gastrointest. Endosc. 56(Suppl.4), S62-S65 (2002).
77. Cope C, Ginsberg GG. Long-term patency of experimental magnetic compression gastroenteric anastomoses achieved with covered stents. Gastrointest. Endosc. 53(7), 780-784 (2001).
78. Fritscher-Ravens A, Mosse CA, Mukherjee D et al. Transluminal endosurgery: single lumen access anastomotic device for flexible endoscopy. Gastrointest. Endosc. 58(4), 585-591 (2003).
79. Pasricha PJ. The future of therapeutic endoscopy. Clin. Gastroenterol. Hepatol. 2(4), 286-289 (2004).
80. Jagannath SB, Kantsevoy SY, Vaughn CA et al. Peroral transgastric endoscopic ligation of fallopian tubes with long-term survival in a porcine model. Gastrointest. Endosc. 61(3), 449-453 (2005).
81. Park PO, Bergstrom M, Ikeda K, Fritscher-Ravens A, Swain P. Experimental studies of transgastric gallbladder surgery: Cholecystectomy and cholecystogastric anastomosis (videos). Gastrointest. Endosc. 61(4), 601-606 (2005).